Abstract:OBJECTIVE: It has been reported that there are differences between in vitro and in vivo matured oocytes for their survival rates following vitrification The purpose of this study is to determine the competency of cryodamage resistance of in vitro matured oocytes in the presence of cysteamine during in vitro maturation (IVM).DESIGN: Animal-model study.MATERIALS AND METHODS: Female mice (CD-1) were stimulated with 10IU PMSG. Oocytes were collected after 48h and the collected oocytes were divided into following groups: (1) Cumulus-oocyte-complex (COC); (2) denuded groups. Both COC and denuded oocytes were cultured in IVM medium containing 75mIU/mL FSH and LH, 10% FBS for 16 h in the presence or absence of cysteamine (200μM). Following culture, the maturated oocytes were either vitrified or inseminated immediately. Vitrification and thawing procedures were performed with McGill Cryoleaf as reported previously. Vitrified oocytes were thawed and inseminated on the other day. Fertilization rate were recorded 24 h after insemination, and early embryonic development were assessed. Statistical differences were considered significant at p<0.05.RESULTS: The presence of cysteamine during IVM significantly increased maturation rate in COC group but had no significant difference in denuded group. The presence of cyseamine during IVM does not improve the survival rate of in vitro matured oocytes with or without cumulus cells during IVM. However, the presence of cumulus cells during IVM had better fertilization rate (p<0.05) compared to the denuded oocytes after vitrification-thawing. The presence of cysteamine during IVM significantly reduced the fragmentation rate in cumulus-intact group compared to cumulus-free group following vitrification-thawing.CONCLUSIONS: The presence of cysteamine during IVM has beneficial effect on both COC and denuded oocytes in terms of their competency of subsequent fertilization and early embryonic development following vitrification. OBJECTIVE: It has been reported that there are differences between in vitro and in vivo matured oocytes for their survival rates following vitrification The purpose of this study is to determine the competency of cryodamage resistance of in vitro matured oocytes in the presence of cysteamine during in vitro maturation (IVM). DESIGN: Animal-model study. MATERIALS AND METHODS: Female mice (CD-1) were stimulated with 10IU PMSG. Oocytes were collected after 48h and the collected oocytes were divided into following groups: (1) Cumulus-oocyte-complex (COC); (2) denuded groups. Both COC and denuded oocytes were cultured in IVM medium containing 75mIU/mL FSH and LH, 10% FBS for 16 h in the presence or absence of cysteamine (200μM). Following culture, the maturated oocytes were either vitrified or inseminated immediately. Vitrification and thawing procedures were performed with McGill Cryoleaf as reported previously. Vitrified oocytes were thawed and inseminated on the other day. Fertilization rate were recorded 24 h after insemination, and early embryonic development were assessed. Statistical differences were considered significant at p<0.05. RESULTS: The presence of cysteamine during IVM significantly increased maturation rate in COC group but had no significant difference in denuded group. The presence of cyseamine during IVM does not improve the survival rate of in vitro matured oocytes with or without cumulus cells during IVM. However, the presence of cumulus cells during IVM had better fertilization rate (p<0.05) compared to the denuded oocytes after vitrification-thawing. The presence of cysteamine during IVM significantly reduced the fragmentation rate in cumulus-intact group compared to cumulus-free group following vitrification-thawing. CONCLUSIONS: The presence of cysteamine during IVM has beneficial effect on both COC and denuded oocytes in terms of their competency of subsequent fertilization and early embryonic development following vitrification.

Study of Roscovitine combined with IGF-1 on oocytes' nuclear and cytoplasm synchronize maturation in vitro

The Effect of Antioxidant Agent During in Vitro Maturation (IVM) of Murine Oocytes on Survival, Fertilization and Early Embryonic Development Following Vitrification

Improved Developmental Competence and Spindle Assembly of in Vitro Maturation of Human Oocytes by Prolonged Culture Duration

Roscovitine induces synchronous maturation of nuclear and cytoplasm of oocytes in goat

In-vitro maturation culture and vitrification of immature oocytes

Effect of Roscovitine Pretreatment for Increased Utilization of Small Follicle-Derived Oocytes on Developmental Competence of Somatic Cell Nuclear Transfer Embryos in Pigs.

Effect of Gonadotrophin on the in vitro maturation of immature oocytes from controlled ovarian stimulation

Factors Affecting the Efficiency and Reversibility of Roscovitine (ROS) Block on the Meiotic Resumption of Goat Oocytes

Optimal Timing of Oocyte Maturation and Its Relationship with the Spindle Assembly and Developmental Competence of in Vitro Matured Human Oocytes.

Clinical study on the application of in vitro maturation treatment in the patients with follicle development retardation in in vitro fertilization cycles

A Prospective Randomized Controlled Trial: Short-Time in Vitro Maturation for Improvement of Oocytes Quality and Reproductive Outcomes

Fertilization of in Vitro Matured Human Oocytes by Intracytoplasmic Sperm Injection （ICSI） Using Ejaculated and Testicular Spermatozoa

The Effects of In Vitro Maturation in Rescue Treatment for Poor Ovarian Responders in In Vitro Fertilization

A Simple Technique for Immature Oocytes Rescue by In-vitro-maturation Culture in Controlled Ovarian Hyperstimulation Cycles

Supplementation of EGF, IGF-1, and Connexin 37 in IVM Medium Significantly Improved the Maturation of Bovine Oocytes and Vitrification of Their IVF Blastocysts

SORT-TERM <i>IN VITRO</i> MATURATION (IVM) CULTURE OF CUMULUS-OOCYTE COMPLEXES IMPROVES SUBSEQUENT EMBRYONIC DEVELOPMENT IN STIMULATED CYCLES.

Inhibiting the meiotic resumption of goat oocytes with roscovitine (ROS) and butyrolactoneI (BL-I)

Research of Pig Oocytes in Vitro Maturation Time

Comparison of two in vitro gonadotrophin priming protocols in maturation treatment of patients with polycystic ovary syndrome

Application of oocytes in vitro maturation in preventing ovarian hyperstimulation syndrome.Jin Rentao

Roscovitine and Trichostatin A Promote DNA Damage Repair During Porcine Oocyte Maturation.